Advancing cancer detection

Israeli biotech Rosetta Genomics boosted its molecular diagnostics capability by purchasing PersonalizeDx in the United States. Rosetta also received US patent protection for its cancer tests.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *